Molecular targeted therapies for breast cancer treatment

Targeting the oestrogen receptor, HER2 (human epidermal growth factor receptor 2) and vascular endothelial growth factor has markedly improved breast cancer therapy. New targeted therapeutic approaches to induction of apoptosis or inhibition of anti-apoptosis, cell cycle progression, signal transduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlotter, Claus M, Vogt, Ulf, Allgayer, Heike, Brandt, Burkhard
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575526/
https://www.ncbi.nlm.nih.gov/pubmed/18671839
http://dx.doi.org/10.1186/bcr2112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575526/
https://www.ncbi.nlm.nih.gov/pubmed/18671839
http://dx.doi.org/10.1186/bcr2112

Ejemplares similares